Decreased signs of inflammation and no erosive progression on ultrasonography at 6 and 12 months in patients with rheumatoid arthritis in adalimumab and methotrexate combination therapy.

Uffe Døhn, Marcin Szkudlarek, Michael Sejer Hansen, Merete Lund Hetland, Annette Hansen, Ole Rintek Madsen, Maria Hasselquist, Mikkel Østergaard

    Original languageEnglish
    JournalAnnals of the Rheumatic Diseases
    Volume69
    Issue number3
    Pages (from-to)457
    Number of pages1
    ISSN0003-4967
    Publication statusPublished - 2010

    Cite this